menu
    • menu

    Company profile for APRINOIA Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    APRINOIA Therapeutics is a developer of innovative diagnostic and therapeutic products designed for preclinical to clinical stages. The company's products focus on neurodegenerative diseases and feature diagnostic and therapeutic product candidates, which target Alzheimer's disease, non-AD tauopathies, Lewy body dementia, and Parkinson's disease, enabling doctors to precisely prescribe and track treatment efficacies as well as...
    APRINOIA Therapeutics is a developer of innovative diagnostic and therapeutic products designed for preclinical to clinical stages. The company's products focus on neurodegenerative diseases and feature diagnostic and therapeutic product candidates, which target Alzheimer's disease, non-AD tauopathies, Lewy body dementia, and Parkinson's disease, enabling doctors to precisely prescribe and track treatment efficacies as well as detect neurodegenerative diseases early in patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    APRINOIA TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    245 Main Street, Cambridge, MA 02142
    Telephone
    Telephone
    +1 6172254415
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aprinoia.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/aprinoia-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    APRINOIA Gets FDA Fast Track For APN-1607 In Supranuclear Palsy Diagnosis
    APRINOIA Gets FDA Fast Track For APN-1607 In Supranuclear Palsy Diagnosis

    21 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/22/2886122/0/en/APRINOIA-Therapeutics-Announces-Fast-Track-Designation-Granted-by-U-S-FDA-to-APN-1607-for-the-Diagnosis-of-Progressive-Supranuclear-Palsy.html

    GLOBENEWSWIRE
    21 May 2024
    Share Share
    APRINOIA's APN-1607 Granted FDA Fast Track For PSP Diagnosis
    APRINOIA's APN-1607 Granted FDA Fast Track For PSP Diagnosis

    20 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/20/2884793/0/en/APRINOIA-Therapeutics-Announces-Fast-Track-Designation-Granted-by-U-S-FDA-to-APN-1607-florzolotau-for-the-Diagnosis-of-Progressive-Supranuclear-Palsy.html

    GLOBENEWSWIRE
    20 May 2024
    Share Share
    APRINOIA Therapeutics Announces Strategic Investment From The ADDF
    APRINOIA Therapeutics Announces Strategic Investment From The ADDF

    11 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/11/2740647/0/en/APRINOIA-Therapeutics-Announces-Strategic-Investment-From-The-Alzheimer-s-Drug-Discovery-Foundation-ADDF.html

    GLOBENEWSWIRE
    11 Sep 2023
    Share Share
    APRINOIA Therapeutics Appoints Mark S. Shearman, Ph.D., as CEO
    APRINOIA Therapeutics Appoints Mark S. Shearman, Ph.D., as CEO

    28 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/08/28/2732754/0/en/APRINOIA-Therapeutics-Appoints-Mark-S-Shearman-Ph-D-as-Chief-Executive-Officer.html

    GLOBENEWSWIRE
    28 Aug 2023
    Share Share
    Ex-US Commerce Secretary Wilbur Ross pairs his SPAC with Alzheimer's biotech
    Ex-US Commerce Secretary Wilbur Ross pairs his SPAC with Alzheimer's biotech

    18 Jan 2023

    // Kyle LaHucik ENDPTS

    https://endpts.com/ex-us-commerce-secretary-wilbur-ross-pairs-his-spac-with-alzheimers-biotech/

    Kyle LaHucik ENDPTS
    18 Jan 2023
    Share Share
    APRINOIA Tx Bags FDA clearance to initiate APNmAb005 Phase 1 clinical trial
    APRINOIA Tx Bags FDA clearance to initiate APNmAb005 Phase 1 clinical trial

    11 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/aprinoia-therapeutics-received-fda-clearance-to-initiate-apnmab005-phase-1-clinical-trial-301519709.html

    PRNEWSWIRE
    11 Apr 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search